Stocks
Funds
Screener
Sectors
Watchlists

Latest HealthInvest Partners AB Stock Portfolio

About HealthInvest Partners AB and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Atle Fund Management AB reported an equity portfolio of $27 Millions as of 30 Sep, 2025.

The top stock holdings of Atle Fund Management AB are LLY, ABBV, NBIX. The fund has invested 11.2% of it's portfolio in ELI LILLY & CO and 8.4% of portfolio in ABBVIE INC.

The fund managers got completely rid off VERONA PHARMA PLC - ADR (VRNA) stocks. They significantly reduced their stock positions in AMGEN INC (AMGN), BOSTON SCIENTIFIC CORP (BSX) and VERTEX PHARMACEUTICALS INC (VRTX). Atle Fund Management AB opened new stock positions in AVIDITY BIOSCIENCES INC (RNA) and CELCUITY INC (CELC). The fund showed a lot of confidence in some stocks as they added substantially to KRYSTAL BIOTECH, INC (KRYS), DISC MEDICINE INC and SOLENO THERAPEUTICS INC (SLNO).

HealthInvest Partners AB Annual Return Estimates Vs S&P 500

New Buys

Ticker$ Bought
avidity biosciences inc240,427
celcuity inc194,869

New stocks bought by HealthInvest Partners AB

Additions

Ticker% Inc.
krystal biotech, inc109
disc medicine inc85.34
soleno therapeutics inc48.42
bicara therapeutics inc38.25
beigene ltd24.39
newamsterdam pharma co nv23.15
irhythm technologies inc18.53
neurocrine biosciences inc16.1

Additions to existing portfolio by HealthInvest Partners AB

Reductions

Ticker% Reduced
amgen inc-42.22
boston scientific corp-31.31
vertex pharmaceuticals inc-26.97
merus n.v.-19.85
stryker corporation-17.1
mirum pharmaceuticals inc-12.45
cencora inc-9.08
eli lilly & co-3.81

HealthInvest Partners AB reduced stake in above stock

Sold off

Ticker$ Sold
verona pharma plc - adr-4,454,720

HealthInvest Partners AB got rid off the above stocks

Sector Distribution

Sector%
Healthcare94
Others6

Market Cap. Distribution

Category%
MEGA-CAP35.3
LARGE-CAP32.2
MID-CAP18.9
SMALL-CAP7.7
UNALLOCATED6

Stocks belong to which Index?

Index%
S&P 50054.2
Others23.5
RUSSELL 200022.3
Top 5 Winners (%)%
Top 5 Winners ($)$
Top 5 Losers (%)%
AUTL
autolus therapeutics plc
-92.0 %
MREO
mereo biopharma group plc
-91.9 %
DXCM
dexcom inc
-91.8 %
UFPT
ufp technologies inc
-90.9 %
ISRG
intuitive surgical inc
-90.8 %
Top 5 Losers ($)$
LLY
eli lilly & co
-26.0 M
ABBV
abbvie inc
-14.0 M
NBIX
neurocrine biosciences inc
-9.8 M
MRK
merck & co. inc
-9.8 M
ISRG
intuitive surgical inc
-9.2 M

HealthInvest Partners AB Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of HealthInvest Partners AB

Last Reported on: 04 Nov, 2025
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions